Sources | Names Used |
---|---|
CTRPv2 | selumetinib:vorinostat (8:1 mol/mol) |
PharmacoGx | selumetinib:vorinostat (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ALG5 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | INPP5F | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-06 |
mRNA | CCDC80 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | TMEM263 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | PARP4 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | PRRX2 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | MCUB | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | RP11-293I14.2 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |